"Among patients hospitalized with COVID-19, treatment with hydroxychloroquine, azithromycin, or both was not associated with significantly lower in-hospital mortality", a recent study published on May 11 concluded.
Thirty percent of black adults and 26% of Latino adults in the country said they know a victim of the coronavirus, who died either from the disease or from complications related to the virus.
The second part of the study is a randomized clinical trial which began last month and is now examining nearly 600 health care workers with 25 to 40 added each day.
Hydroxychloroquine, a drug used to treat lupus and rheumatological disorder, has received a massive amount of publicity this year. I'm taking the two - the zinc and the hydroxyl.
"I would never begrudge any American taking the advice of their physician", he added.
"As far as the president is concerned, he's our president and I would rather he not be taking something that has not been approved by the scientist", she said.
While the University of Oxford trial is taking place in a controlled clinical environment, the World Health Organization has warned that some individuals were self-medicating and risked causing themselves serious harm.
That veterans study, funded by grants from the NIH and the University of Virginia, was not a rigorous experiment, but a retrospective analysis by researchers at several universities looking at the impact of hydroxychloroquine in patients at veterans' hospitals across the nation.
"These trials will give us the best understanding of how safe and effective these drugs might be across different populations and age groups", said Nick Cammack, COVID-19 Therapeutics Accelerator Lead at the Wellcome Trust, a UK-based medical research charity which is helping to fund the trial.
"While clinical trials are ongoing to determine the safety and effectiveness of these drugs for Covid-19, there are known side effects of these medications that should be considered FDA commissioner Stephen M Hahn said in a statement issued in late April".
Later, the White House doctor spoke out about Trump's use of HCQ, saying "the potential benefit from treatment outweighed the relative risks", USA Today reported.